ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 136

Transcriptomic Analysis of Ultrasound-Guided Synovial Biopsies from Patients with Juvenile Idiopathic Arthritis

Samuel Dowling1, Mohammad Daud Khan2, Tyler Therron3, Matthew Dapas2, Radmila Nafikova2, Kainat Mian2, Deirdre DeRanieri4, Deborah Winter5 and Harris Perlman2, 1Lurie Children's Hospital / Northwestern Univ., Chicago, IL, 2Northwestern University, Chicago, IL, 3Northwestern Feinberg School of Medicine, Chicago, IL, 4Division of Rheumatology, Department of Pediatrics, Northwestern Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital, Chicago, IL, USA, Chicago, IL, 5Northwestern University, Skokie, IL

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Friday, March 20, 2026

Title: Posters: Genetics and Pathogenesis II

Session Time: 6:00PM-7:00PM

Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common pediatric rheumatologic disease, with an incidence of 2–23 new cases per 100,000 children, and is associated with significant morbidity. Analyses of peripheral blood and synovial fluid have provided limited insight into JIA pathogenesis and have yet to identify reliable biomarkers to predict disease course and/or drug response. Novel approaches utilizing minimally invasive ultrasound-guided synovial biopsy (MIUGSB) allow direct analysis of the synovial tissue, which is the primary site of inflammation in JIA.

Methods: Patients with JIA, who were at least 5 years old and were undergoing ultrasound-guided intra-articular corticosteroid injection (IACI), were eligible for synovial tissue biopsy. This study was approved by Lurie Children’s Hospital IRB. At time of IACI, five to eight samples of synovial tissue from a single knee per patient were retrieved via MIUGSB by a pediatric rheumatologist. Synovial tissue samples were either formalin-fixed and paraffin-embedded (FFPE) for spatial transcriptomic profiling on the 10x Genomics Xenium platform using a custom 216-gene panel, or enzymatically digested and sorted for generation of single cell 5’ libraries and RNA sequencing.

Results: We obtained high quality knee synovial biopsies from 17 patients with oligoarticular or polyarticular JIA (Table 1); all patients tolerated the procedure well. Single-cell RNA sequencing (scRNA-seq) detected a median of 1,054 to 3,632 genes per cell from 10 patients, with data currently under analysis. To date, spatial transcriptomic analysis has been performed on synovial tissue from 4 of these patients. In addition, FFPE synovial tissue samples from 5 additional patients have been prepared for Xenium-based spatial transcriptomics. We identified 11 clusters that comprise diverse immune cell populations—including monocytes, macrophages, T-, B-, plasma, and dendritic cells—organized regionally in relation to the synovial lining and sublining layers.  In contrast to samples from patients with rheumatoid arthritis (RA) in which fibroblast-like synoviocytes outnumber macrophages, most synovial cells from JIA samples were macrophages (Figure 1). Future studies will delineate the topography of the individual subpopulations in JIA synovium compared to RA synovium.

Conclusion: This study demonstrates the feasibility of concomitantly leveraging scRNA-seq to identify transcriptional signatures and spatial transcriptomics to characterize immune-stromal architectures associated with JIA disease. Additionally, these findings will be correlated with prospective clinical data as well as analysis from peripheral blood and synovial fluid, offering insight into pediatric synovial immunopathology and potential insight into predictors of immune response.

Table 1. Clinical Characteristics of Patient Participants (n=17)Supporting image 1

Figure 1. Characterization of Immune and Non-immune cells from Knee Synovium of Patients with JIASupporting image 2A, Histology of synovial tissue, illustrating representative hematoxylin and eosin (H&E), anti-CD45 immunohistochemistry (IHC), and anti-CD68 IHC. B, Uniform Manifold Approximation and Projection (UMAP) of annotated cell types from reference CosMx dataset for label transfer to Xenium dataset. C, Spatial plot of JIA synovial tissue, illustrating representative cell annotation.


Disclosures: S. Dowling: None; M. Khan: None; T. Therron: None; M. Dapas: None; R. Nafikova: None; K. Mian: None; D. DeRanieri: None; D. Winter: None; H. Perlman: AbbVie/Abbott, 2.

To cite this abstract in AMA style:

Dowling S, Khan M, Therron T, Dapas M, Nafikova R, Mian K, DeRanieri D, Winter D, Perlman H. Transcriptomic Analysis of Ultrasound-Guided Synovial Biopsies from Patients with Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/transcriptomic-analysis-of-ultrasound-guided-synovial-biopsies-from-patients-with-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transcriptomic-analysis-of-ultrasound-guided-synovial-biopsies-from-patients-with-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology